Introducing ePrescribing State Law Review SubscriptionIcons_ePrescribe_State_Law_Iso

The ePrescribing State Law Review combines access to Point-of-Care Partners policy experts with timely analyses of evolving laws and regulations governing electronic prescriptions. The service includes perpetually updated data sets for all 50 states and Washington, DC that provide the foundation for companies with a stake in ePrescribing to easily assess their compliance with state and federal rules and regulations and to stay ahead of the evolving eRx landscape.

Who is this meant for?

The ePrescribing State Law Review is primarily used by:

  • Health tech vendors who have end users across different states
  • Life sciences companies

However, any stakeholder impacted by varying state ePrescribing policy related to prescribing authority, controlled substance requirements and Prescription Drug Monitoring Programs (PDMPs) would benefit from the information provided.

What does the ePrescribing Law Review cover?

Fully updated quarterly with intermittent alerts for urgent changes, the Law Review covers ePrescribing regulations for the 50 states and Washington, D.C. including:

  • Comprehensive research of federal, local, and state-by-state Board of Pharmacy (BOP) rules, regulations, and laws on ePrescribing, with real-time updates
  • Local output format requirements for faxed and printed prescriptions
  • Information about rules and documentation requirements for mid-level providers for legend and controlled substance prescriptions
  • State-level guidelines and policies related to biosimilars interchangeability
  • State-level telehealth ePrescribing guidelines on: 
    o    Controlled substance restrictions
    o    State-prescribing licensure requirements 
    o    Patient/Provider relationship requirements
    o    Technology allowed (video required or audio-only allowed)
  • State requirements for ePrescribing system approval—addresses, URLs and BOP executive contact information are provided
  • Information about controlled substance schedule variances for states that categorize certain drugs differently from the DEA
  • A data table summarizing each state’s requirements as a shortcut reference for legal compliance during software programming
  • A detailed backup with relevant regulations and history of changes is provided separately

How do I access ePrescribing State Law Review?

The ePrescribing State Law Review is offered on a subscription basis and includes:

        • Access to the user-friendly online portal featuring:
          • A 50-state grid
          • Indicators/flags alerting users of what states had new or changing policy
        • Sentinel alerts for important changes between quarterly release dates
        • Training discussion to review material
        • Quarterly updates to data within the portal
        • Executive summary of changes each quarter
        • On-demand presentation of key changes each quarter
        • 3 hours consulting time each quarter


Icons_Drive-Efficiencies_Iso Icons_Solution_Iso Icons_Exceed-Expectations_Iso Icons_Strategy-1_Iso

Save time by using curated policy intelligence, allowing your team to focus on your core mission

Drive operational and clinical efficiencies within your organization.


Enhance the policy integrity of your solution.


Exceed client expectations by staying ahead of policy changes.


Identify opportunities for strategic shifts or policy influence


Solution Examples

Biosimilar Substitution Report
Biosimilar Substitution Report
EPCS Table
EPCS Table
eRx Grid (Expanded)
ePrescribing Grid
Midlevel Prescribing Authorizations Report
Midlevel Prescribing Authorizations Report.
PDMP Report
Prescription Drug Management Programs (PDMP) Report
Rx Delivery Method Report

ePrescription Delivery Method Report

Rx Formating Rules Report
ePrescribing formatting rules report
Schedule Variance Report
Schedule Variance Report
Telemedicine Report
Telemedicine Report